Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected ...Middle East

Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations.

Read more...

Read More Details
Finally We wish PressBee provided you with enough information of ( Zepbound sales keep soaring, despite demand for weight-loss drugs growing slower than expected )

Also on site :

• China May retail sales sharply beat estimates; industrial output misses expectations
• The 6th Qingdao Multinationals Summit to Be Held on June 18, Signaling China's Commitment to Expanding Opening-Up and Boosting Foreign Investment
• Zimbabwe: Labour MP Butler Distances Herself From Summit With Zimbabwe's First Lady As Activists Threaten Protests